HCPCS Level IIdrugActive

J2329

Inj ublituximab-xiiy, 1 mg

BETOS: O1E

Effective: 2023-07-01

Referenced in 1 policies

Description

Injection, ublituximab-xiiy, 1mg

Medicare Part B Drug Pricing

Average Sales Price (ASP) data for Q1 2026

Drug Name

Briumvi

Manufacturer

TG Therapeutics, Inc.

HCPCS Dosage

1 MG

Billing Units

150.0000

NDC Products

asp

Pricing Source

Medicare Part B drugs are reimbursed at ASP + 6%. Pricing updates quarterly based on manufacturer-reported data.